Texas Oncology - Central South, Austin
University of Texas Southwestern Medical Center/Clinical Research Department, Dallas
Texas Oncology - West Texas, Odessa

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07218146

A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

Texas Oncology - Central/South Texas, Austin
Texas Oncology - Northeast Texas, Tyler

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT06646276

A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy

MD Anderson Cancer Center, Houston

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT07564401

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Dallas
Avenzo Therapeutics Recruiting Site, Houston
Avenzo Therapeutics Recruiting Site, San Antonio

A’ fastadhÌre 1/2

Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07038343

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

The University of Texas MD Anderson Cancer Center, Houston
Texas Oncology Cancer Center, Sugar Land

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT06712355

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

MD Anderson Cancer Center Uni of Te, Houston

A’ fastadhÌre 1/2

Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 27 Lùna 2026 · NCT06726148

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Texas Oncology - DFW, Dallas
MD Anderson Cancer Center, Houston
Texas Oncology - Northeast, Tyler

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT06892548

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

UT Southwestern Medical Center, Dallas
MD Anderson Cancer Center, Houston

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT07488923

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
University of Texas Southwestern Medical Center, Dallas

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT06095505

A Study of MGC026 in Participants With Advanced Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston
University of Texas Health Science Center at Houston, Houston

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT06242470

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

The University of Texas, MD Anderson Cancer Center, Houston
UT Health Mays Cancer Center, San Antonio

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT05592626

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Clinical Trial Site, San Antonio

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT07749586

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Houston Methodist Cancer Center, Houston
University of Texas Md Anderson Cancer Center, Houston
Texas Oncology, P.A. - Tyler, Tyler

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06203210

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston
NEXT Dallas, Irving
South Texas Accelerated Research Therapeutics, LLC, San Antonio

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT06131840

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

Mays Cancer Center / University of Texas, San Antonio, San Antonio

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Iuch 2026 · NCT05652686

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

The University of Texas MD Anderson Cancer Center, Houston
Oncology Consultants, PA- Houston, Houston
Next Oncology Dallas, Irving

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Iuch 2026 · NCT07174583

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

University of Texas MD Anderson Cancer Center, Houston

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Ògmh 2026 · NCT06598306

A Study of LY4175408 in Participants With Advanced Cancer

MD Anderson Cancer Center, Houston

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Ògmh 2026 · NCT07046923

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

START Dallas, Fort Worth

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Ògmh 2026 · NCT07517198

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

NEXT Oncology Austin, Austin
NEXT Oncology San Antonio, San Antonio

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Gibl 2026 · NCT07424547

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

M D Anderson Cancer Center, Houston

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Màrt 2026 · NCT06769126

Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

Michael E. DeBakey VA Medical Center, Houston, TX, Houston

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Màrt 2026 · NCT06681220

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

NEXT Oncology - Dallas, Dallas
START San Antonio, San Antonio

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Gearr 2026 · NCT07030257

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

Mary Crowley Cancer Research, Dallas

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Faoi 2026 · NCT05490472

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

The University of Texas MD Anderson Cancer Center (site 127), Houston

A’ fastadhÌre 1/2

Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 11 Dùbh 2025 · NCT03556228

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Research Site 135, Austin
Research Site 120, Dallas

A’ fastadhÌre 1/2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Samh 2025 · NCT05914116

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

The University of Texas MD Anderson Cancer Center, Houston

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2025 · NCT06805825

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.